Our findings underscore the importance of further investigating the role of the oxoacid metabolic process in neuroblastoma and suggest that targeting DHODH may present a promising approach for disrupting the metabolic networks that sustain cancer cell viability and progression. This evidence concerns the gene DHODH and cancer.